EI
ITCI
EAM Investors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-67,143
| Closed | -$4.81M | – | 344 |
|
|
2023
Q4 | $4.81M | Buy |
+67,143
| New | +$4.81M | 0.85% | 10 |
|
|
2023
Q3 | – | Sell |
-29,789
| Closed | -$1.89M | – | 397 |
|
|
2023
Q2 | $1.89M | Buy |
+29,789
| New | +$1.89M | 0.35% | 114 |
|
|
2022
Q3 | – | Sell |
-32,849
| Closed | -$1.88M | – | 360 |
|
|
2022
Q2 | $1.88M | Sell |
32,849
-7,481
| -19% | -$427K | 0.46% | 78 |
|
|
2022
Q1 | $2.47M | Sell |
40,330
-2,074
| -5% | -$127K | 0.46% | 72 |
|
|
2021
Q4 | $2.22M | Buy |
+42,404
| New | +$2.22M | 0.36% | 95 |
|
|
2021
Q3 | – | Sell |
-48,220
| Closed | -$1.97M | – | 408 |
|
|
2021
Q2 | $1.97M | Buy |
+48,220
| New | +$1.97M | 0.3% | 138 |
|
|
2020
Q4 | – | Sell |
-38,600
| Closed | -$990K | – | 399 |
|
|
2020
Q3 | $990K | Buy |
+38,600
| New | +$990K | 0.23% | 207 |
|
|
2016
Q3 | – | Sell |
-20,737
| Closed | -$805K | – | 371 |
|
|
2016
Q2 | $805K | Sell |
20,737
-9,861
| -32% | -$383K | 0.12% | 279 |
|
|
2016
Q1 | $851K | Sell |
30,598
-75,645
| -71% | -$2.1M | 0.13% | 270 |
|
|
2015
Q4 | $5.72M | Buy |
106,243
+11,075
| +12% | +$596K | 0.75% | 6 |
|
|
2015
Q3 | $3.81M | Sell |
95,168
-57,221
| -38% | -$2.29M | 0.6% | 23 |
|
|
2015
Q2 | $4.87M | Buy |
152,389
+106,257
| +230% | +$3.4M | 0.57% | 30 |
|
|
2015
Q1 | $1.1M | Buy |
+46,132
| New | +$1.1M | 0.13% | 295 |
|